About
Nick Roelofs has more than 40 years of experience in the life sciences tools and diagnostics industry, including roles as President of Agilent Technologies' Life Sciences Group and Life Science Group Operations Officer at Bio-Rad Laboratories. He holds two PhDs with expertise in chemistry and has advised private equity firms such as Summa Equity and Nordic Capital, including on Olink's sale to Thermo Fisher. At Sciety, he evaluates investment opportunities and supports portfolio company growth.
Invests in
BiotechMedical Devices
Experience
- Capitainer ABBoard Membercurrent2025 — present
- PeptiSystems ABBoard Membercurrent2025 — present
- SeerBoard Membercurrent2024 — present
- ScietyVenture Partnercurrent2024 — presentStockholm, Stockholm County, Sweden
- Nordic CapitalIndustrial Advisorcurrent2014 — present
- LGCBoard Membercurrent2016 — presentTeddington, Greater London, United Kingdom
- 908 DevicesAdvisory Board Membercurrent2015 — presentBoston, Massachusetts
- One BioMed Pte LtdChairperson of the Board2017 — 2026Singapore, Singapore
- Summa EquityIndustrial Advisor2016 — 2025Stockholm County, Sweden
- ScalebioBoard Member2021 — 2025
- VelseraBoard Member2022 — 2025United States
- SengenicsChairman Of The Board2020 — 2024
- Olink ProteomicsBoard Member2019 — 2024Stockholm County, Sweden
- DA32Board Member2021 — 2023United States
- The Binding SiteBoard Member2014 — 2023United Kingdom
- InSilixaBoard Member2015 — 2021
- Boreal GenomicsChairman2014 — 2021Vancouver, British Columbia, Canada
- BluebeeChairman2016 — 2020Rijswijk, Gelderland Province, Netherlands
- Exploit Technologies Pte LtdChairman Project Advisory Committee2015 — 2020Singapore
- Life Science TelemetryChief Executive Officer2013 — 2020Millbrae, California
Education
- University of Nevada, RenoPh.D., Chemistry1983 — 1987
- Iowa State UniversityMaster of Science (MS), Organic Chemistry1979 — 1983
- Simpson CollegeChemistry, Biology1975 — 1979
Skills & more
Business Development23New Business Development5Lifesciences36Biotechnology84Commercialization50Genomics32R1Molecular Biology15Drug Discovery15Medical Devices27Biochemistry10Biopharmaceuticals23
+12 more
ChemistryPCRProduct LaunchFDAHardware DiagnosticsDrug DevelopmentGLPGMPLeadershipStrategic PlanningStart-upsClinical DevelopmentLanguages English · French · German
From Nick's professional profile.
Same school
Also attended University of Nevada, Reno8
Jack DaileyFund Controller at HeadlineCraig J. LewisBoard Member at MassChallenge MexicoNikul BhattSenior Partner at KFC VenturesDeane AlbrightAdvisory Board at Reno Seed FundBryan McArdleAdvisory Board at Reno Seed FundJim StarrAdvisory Board at Reno Seed Fund
+ 2 more
Also attended Simpson College1
Shared employers
Also worked at Summa Equity12
Tommi UnkuriMember of the Board at ScietyKenneth J. BraithwaiteVenture Partner at Scout VenturesTom Even MortensenVenturist at SandwaterJen Lee KossFounding Partner at SpringbankKees KruythoffExternal Board Member at NicoyaKarl Magnus SmebyDirector at Equip Capital AS
+ 6 more
Also worked at Bluebee1
Also worked at Agilent Technologies26
Martin ScottSenior Technical Advisor at Samsung Catalyst FundTyler AmesEntrepreneur-In-Residence at The Innovation SpaceStuart HwangVenture Partner at RDiscoveryEmily LeproustCEO, Twist Bioscience & Founding Pillar at Pillar VCAimee RaleighPrincipal at Atlas VentureGrace MahSV2 Board Member at Silicon Valley
+ 20 more
Also worked at Bio-Rad Laboratories6
Investments
Board seats
908 DevicesThe Binding SiteVelsera
Investor
Olink
Per the firm's website.
Colleagues at Sciety
Andreas Lindblom
Managing Partner at Sciety
Bengt Julander
Senior Advisor at Sciety
Charlotte Smirnova
Corporate Communications Manager at Sciety
Christina Sterner
Operations & Compliance Manager at Sciety
Daniel Borg
IT Manager at Sciety
Dawid Myslinski
Director – Equity Capital Markets at Sciety
Erik Röjvall
Head of Corporate Finance at Sciety
Fredrik Niléhn
Senior Associate – Corporate Finance at Sciety